Microbiological Expertise #
Dr Jonathan Curry #
Dr Curry holds a PhD in Environmental Toxicology and is highly knowledgeable in a range of laboratory techniques including microbial cultivation and screening, chemical analysis, method validation, safety testing, regulatory compliance, and study design. With a strong foundation in mycology, he is experienced in maintaining microbial culture collections and optimizing growth parameters while preventing cross-contamination. Dr Curry currently works as a scientific consultant on global projects which require his knowledge of the behaviour of chemicals within complex biological systems, including commercial mushroom producers and biotechnology companies around the world.
IP protection, Licensing & Patents #
Parminder Singh #
Parminder Singh is a seasoned executive with more than 30 years of technical, operations and international business in both corporate and entrepreneurial environments. He has worked in undercapitalized start-ups through to Fortune 100 multinational corporations. His industry experience includes software & product development, intellectual property, with particular experience with medical devices, and satellite systems.
D.Chem, EU-GMP Expertise #
Dr. Naeem Khan #
Naeem holds a PhD in Chemistry and has over 60 years of experience in industrial pharmaceutical production. Naeem provides notable competence for EU GMP certification, development of Quality Management systems, validation of manufacturing processes and analytical methods, supplier approval and Pharmacovigilance.
Medicinal Plant Licencing, Product Registration and Compliance. #
Denzil Phillips #
Denzil has worked for over 30 years in the field of botanicals and natural productions particularly in Africa, Asia, and the Caribbean. Denzil specializes in the design and implementation of projects in the field of medicinal plants and related botanical products. Providing advice on regulations and certifications for new plant-based medicines, Denzil also serves as an associate consultant at Global Regulatory Services, one of the leading regulatory consultancies in Europe.
Legal Advisor #
David Wood #
David’s regulatory practice includes drafting applications for, interacting with Health Canada in respect of, and otherwise advised in relation to, activities under dealer’s licences for LSD, DMT, psilocybin, MDMA and other psychedelics, including international sale of psychedelics manufactured in accordance with GMP as an API in drug products for use in clinical trials. David’s intellectual property practice includes drafting and prosecuting patent applications, assessing patentability of technology, validity of patents and potential patent infringement exposure. David also completed patent-related due diligence and manages multi-jurisdictional patent portfolios. David’s commercial practice is key to develop relationships with complex intellectual property and regulatory aspects. David also holds a PhD in biochemistry. His graduate-level education in structural biochemistry, synthetic organic chemistry, physical chemistry, plant biochemistry and natural products chemistry provides a strong technical background for advising clients working with psychedelics.
Pharmaceutical Manufacturing #
Professor Robert Britton #
Professor Robert Britton obtained his B. Sc. from the University of Waterloo in 1996 working with Professor Victor Snieckus. He then earned a Ph. D. in natural product isolation, structural elucidation and total synthesis from the University of British Columbia in 2002 with Professors Edward Piers and Raymond Anderson. He spent two years at the University of Cambridge with Professor Ian Paterson as an NSERC PDF then joined the Process Research Group at Merck as a Senior Scientist in 2004. In 2005, he started an independent academic career at Simon Fraser University and was promoted to Professor in 2015. Professor Britton has broad research interests that include natural product drug discovery, medicinal chemistry, radiotracer development and insect communication. Research in these areas have led to commercial traps for bed bugs and other crop pests, 18F-labelled amino acids and peptides for PET imaging in oncology, new tools for late-stage modification of drug leads, new processes for improving the manufacture of drugs, and new strategies for synthesizing structurally complex natural products.
